ArticleScientific reports2025
Clinical, paraclinical, therapeutic features of acute decompensated heart failure in a Moroccan population.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute decompensated heart failure (ADHF) is a major health challenge globally, with high morbidity and mortality. Data from North African populations remain limited. This study aims to describe the clinical profile, precipitating factors, management, and short-term outcomes of patients admitted with ADHF to a tertiary care center in Morocco. We conducted a retrospective study of 138 Moroccan patients admitted with ADHF at Ibn Rochd University Hospital, Casablanca, between 2017 and 2019. Clinical, paraclinical, therapeutic features, and outcomes were analyzed. The mean patient age was 60.45 ± 15.77 years, with a male-to-female ratio of 1.6. Common risk factors included hypertension (36.2%), diabetes (28.3%), and smoking (37.7%). Prior cardiovascular disease was observed in 45.7%, and 32.6% had previous ADHF hospitalizations. On admission, 65.9% were in NYHA class III. The main precipitating factor was bronchopulmonary infection (35.5%). Ischemic heart disease (43.4%) was the leading etiology. Reduced LVEF was seen in 56.5%, HFmrEF in 20.3%, and HFpEF in 23.2%. Cardiogenic shock (10.9%), COPD (9.4%), and renal dysfunction were significant mortality predictors. Beta-blockers were restarted within five days in 33.3%. Clinical improvement occurred in 69.6% of patients; in-hospital mortality was 18.1%. ADHF in Moroccan patients presents at a younger age, with ischemic heart disease as the leading cause. Early intervention, improved adherence, and systemic healthcare strategies are essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.